Nicotine pouches get FDA approval

In a First-of-Its-Kind Decision, FDA Will Allow Marketing of Nicotine Pouches
This marketing decision from the FDA covers 2 nicotine strengths, 3 mg and 6 mg, and 10 flavors of the small tobacco-free synthetic pouches.
Zyn nicotine pouches get FDA approval
FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products' appeal to teens.
FDA authorizes Zyn nicotine pouches, cites lower risk than cigarettes
The FDA authorized the marketing of 20 Zyn products on Thursday, marking the first allowance for the fast-growing nicotine pouches.
FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers
Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit cigarettes.
FDA authorizes sale of Zyn nicotine pouches, saying public health benefits outweigh risk
Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned 119 retailers to stop selling Zyn to underage people, and the company was ordered to pay $1.2 million last year for violating Washington, D.C.’s smokeless tobacco ban.
FDA authorizes marketing of nicotine pouches for the first time
These items have become popular in c-stores as traditional tobacco sales plunge, and their approval sets the stage for continued growth.
US FDA grants first market authorization of nicotine pouches to Zyn
The U.S. Food and Drug Administration authorized the marketing of 20 Zyn products on Thursday, marking the first such move by the regulator for the fast-growing nicotine pouches segment in the country.
FDA officially authorizes Zyn nicotine pouches for sale following health review
The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an "extensive scientific review" about their safety.
FDA will allow Zyn nicotine pouches to stay on the market
Zyn products will be allowed to stay on the market after federal health officials said Thursday that the popular nicotine pouches can help adult smokers cut back or switch completely.
FDA approves sales and marketing for Zyn nicotine pouches
Marketing for the popular nicotine pouch product, Zyn, has been approved by the U.S. Food and Drug Administration to help smokers quit cigarettes and other tobacco products.
Nicotine pouches get FDA approval, with some calling them Gen Z's favorite weight loss hack
Little pouches of nicotine sold by the brand ZYN were given the green light for marketing this week through the U.S. Food and Drug Administration’s premarket tobacco product application (PMTA) pathway.
CBS News3d
What is Zyn? FDA OKs sales, but health concerns of the controversial nicotine pouches remain
Unlike smoking and vaping, Zyn is smoke- and tobacco-free — but the pouches still contain nicotine, an addictive chemical. This makes the product legal only for those 21 and above. The brand's ...
WHYY1d
FDA regulation of nicotine pouches can help prevent youth use, say Rutgers researchers
Nicotine pouches are a newer class of smokeless products that don’t contain tobacco. Zyn became the first FDA-authorized ...
Biden releases 11th-hour plan to lower nicotine in cigarettes
The Food and Drug Administration’s plan to slash nicotine to minimally or nonaddictive levels represents a last-ditch effort ...
Why is the tobacco industry celebrating Sweden’s anti-smoking success?
Long sensing the way the winds were changing on attitudes to cigarettes, the industry has been pivoting to new products, such ...
US regulators propose capping nicotine in cigarettes at non-addictive levels
U.S. regulators are proposing to cap the amount of nicotine in cigarettes at non-addictive levels, in a potential world-first ...